Introduction. Pulmonary thromboembolism (PTE) represents a medical emergency and is the third most common cause of mortality after myocardial infarction and stroke. The purpose of this study was to describe the characteristics and management of patients with PTE admitted in a referral emergency hospital in Romania.
INTRODUCTION
Pulmonary thromboembolism (PTE) represents a medical emergency and is the third most common cause of mortality after myocardial infarction and stroke [1] . The incidence of PTE among the European population exceeds 1 per 1 000 [2] . There are several international registries created in order to evaluate the incidence, demographic and clinical characteristics, as well as prognosis of patients diagnosed with PTE [3, 4] . In 2009, The Romanian Registry of Pulmonary Thromboembolism (RO-TEP) has been created with a priority in evaluating epidemiologic, therapeutic and clinical outcome differences in patients admitted for PTE in several hospitals in Romania. Data reported so far is scarce and the RO-TEP Registry can thus far offer an accurate view on PTE patients characteristics and management [5] . Nonetheless, the results of this registry are still unpublished and data on characteristics of management in emergency hospitals is not currently available.
The purpose of this study was to describe the characteristics and management of patients with PTE admitted in a referral emergency hospital in Romania.
MATERIAL AND METHODS
We retrospectively reviewed all cases of PTE diagnosed in a county emergency hospital during a 2-year period from January 2014 through December 2016. Patients with acute PTE were identified by a data search of the diagnostic codes of all discharge diagnoses (primary and secondary diagnoses). The medical records of all of the patients with a diagnosis of PTE were reviewed for objective evidence of PE. Demographic, clinical and paraclinical tests data was retrieved from the medical records.
Probability and severity scores were calculated retrospectively, according to the European guideline for diagnosis and management of pulmonary embolism (ESC guideline) [6] .
In order to characterize PTE clinical patterns according to age, in the analysis, patients were further divided into two groups, Group 1 with 54 (24.4%) patients under 50 years of age and Group 2 with 167 (75.6%) patients aged 50 years or older.
Ethical approval for the study was granted by the Hospital Committee for Research Ethics.
Statistical analysis
The categorical variables were presented as counts and percentages, while continuous variables were presented as mean values ± standard deviation. The frequency of clinical and paraclinical characteristics in the groups was compared using two-bytwo contingency 
RESULTS
During the 2 year study period, 221 patients (48.87% male, male: female ratio 1:1.04) were diagnosed with PTE in our hospital, summing up to 0.31% of all hospitalizations. Mean age at diagnosis was 61.76 years (range 21-94 years). Two (0.9%) patients died during hospitalization.
Diagnosis of PTE was proven following a combination of clinical evaluation and laboratory and imaging tests. Clinical evaluation, estimation of Wells score and revised Geneva score were done in all patients. D-dimer levels were measured in 37.1% of patients, lower limb ultrasound for deep venous thrombosis (DVT) was done in 51.1% patients, 2D and Doppler echocardiography in 37.5% patients and chest computer tomography in 90.04% of patients.
Clinical presentation
Clinical picture in patients diagnosed with PTE in the emergency department is displayed in Table 1 . Dyspnoea was the most frequent symptom reported followed by pleuritic chest pain and unilateral leg pain, whereas hemoptysis and fever were found in only a minority of patients. Clinical signs of DVT were present in 72 (32.6%) cases and 40 (18.1%) patients had a history of PTE. Tachycardia, defined as a heart rate over 100 bpm, was found in 87 (39.3%) patients.
Up to 72.8% of patients had at least one thrombotic risk factor. Patient comorbidities and risk predictors are detailed in Table 2 . AF -atrial fibrillation, NOAC -direct oral anticoagulant, DVT -deep vein thrombosis, HF-heart failure, LV -left ventricle, PTE -pulmonary thromboembolism, RV -right ventricle, VTE -venous thromboembolism.
Probability of PTE and risk stratification
Pre-test probability was assessed using both Wells and revised Geneva scores, the simplified versions. Wells score misclassified as PE unlikely 22.1% of patients, whereas the revised Geneva score misclassified significantly more, 40.2% of patients that were subsequently diagnosed with PE (Table 3) .
Based on patient clinical status upon presentation, 12.6% of patients were classified as high risk PTE (with shock/hypotension) and the remainder as non-high risk. According to the original version of the PESI (Pulmonary embolism severity index) score, a quarter of patients were at high or very high mortality risk, while another quarter was at low risk (Table 4) . 
Treatment
The mean length of hospitalization was 10.3 ± 4.6 days. No difference in length of hospital stay was found comparing patients initiated on nonantivitamin K oral anticoagulants (NOAC) versus those receiving parenteral anticoagulation (10.8 ± 4.4 vs. 10.6 ± 4.2 days, p-value 0.8) during hospitalization. With respect to treatment, in 96.8% of patients anticoagulation with either unfractioned heparin (UFH), low molecular weight heparin (LMWH) or NOAC was initiated in the hospital. Three patients had major trauma that impeded anticoagulant administration while for the remainder, no contraindication was found. UFH was the preferred anticoagulant during hospital stay (73.7%, p < 0.001). Upon discharge, anticoagulation was recommended in 205 (92.7%) patients. Vitamin K antagonists (AVK) were the preferred anticoagulant (71.7%, p < 0.001) whereas NOAC were recommended in 26.3% of patients.
Thrombolysis was used in 18 (8.4%) cases, in 17 cases as systemic thrombolysis and in 1 patient as catheter directed local thrombolysis (Table 5) . From these patients, 7 (38.8%) received primary reperfusion. 
PTE in young patients
Young patients, under 50 years of age, represented almost a quarter of the PTE patients. Their clinical and biological profile as compared to that of older patients with PTE is represented in Tables  1-2 . Patients clinical probability for PTE in the two groups, based on Wells and Geneva revised scores, is illustrated in Table 3 and the PESI score in Table 4 .
Older patients had more frequently a history of hospitalization for HF or atrial fibrillation (AF) during the previous 3 months, and a history of cancer, while younger patients had more frequently a form of thrombophilia or a previous thromboembolic event (Table 2) . Older patients presented more frequently with chest pain and dyspnea, while younger patients presented with clinical signs of DVT ( Table 1) . The clinical presentation in older patients was more severe with higher PESI score and a longer hospital stay ( Table 6 ). The type of anticoagulant treatment did not differ between groups (Table 5 ). The Wells score indicated 'PTE likely' more frequently than the revised Geneva score in the patients diagnosed with PTE (Table 3) . 
DISCUSSION
In the present study we analyzed the clinical and paraclinical profile of patients admitted for PTE in a major emergency hospital from Romania. PTE diagnosis represented 0.31% of all hospitalizations during the 2-year studied period, an incidence rate similar to those reported in the United States (between 0.047-0.40%) [7] . Our data is limited to PE patients who were hospitalized, and PTE diagnosis could be more frequent in the emergency department, even though admittance rates reported in the US are around 86% [8] .
The two most frequent symptoms were dyspnea and pleuritic chest pain, whereas clinical signs of DVT appeared in a third of patients only, thus emphasizing once more that clinical suspicion of PTE should be based on a combination of signs and symptoms as the Wells and revised Geneva scores taken into consideration [6] . In the present study, which evaluated patients diagnosed with PTE, the revised Geneva score indicated significantly more frequently a low probability for PTE than the Wells rule. The retrospective calculation of these scores may explain the difference between the two scores; however, there are several other studies that emphasize the same discrepancy [9] .
In less than a quarter of patients we found no thrombotic risk factors, a result in accordance with other studies reporting percentages of 15-40% of unprovoked PE [10] . Even though in younger patients risk factors are frequently absent, in our study there was no difference between young and older patients regarding the number of unprovoked PTE [11] . The emergency profile of the hospital in which the study was undertaken might have led to a selected population of young patients with a more severe clinical status or comorbidities. For instance, there were no differences in the percentage of young and older patients with limb fractures or major trauma. Nonetheless, the profile of thrombotic risk factors differs between groups, with thrombophilia being more frequent in the young, while cancer and prior hospitalizations for HF or AF are more frequent in the older patients as it would be expected considering the age-dependent prevalence of the respective diseases in the general population [12, 13] .
Diagnosis of PTE in our hospital is based on internal protocols in accordance with the ESC guidelines. Therefore, after clinical evaluation and PTE probability assessment, in most cases, CT angiography was the next diagnostic step as it is readily available, preceded or not by D-Dimer testing as dictated by the clinical probability scores [6] . Two thirds of patients were diagnosed with central PTE at CT angiography, defined as thrombi in the lobar arteries. Interestingly, there was no difference in the prevalence of central PE between the two studied groups, even though the severity of clinical presentation in the older patients was significantly higher as assessed by the PESI score. However, we found similar proportions of RV dysfunction and dilation assessed by echocardiography in the young versus older patients. This could be the result of the overall greater cardiovascular fitness and reserve of young patients along with the increased number of comorbidities in the older patients, especially HF. The in-hospital mortality was very low (0.9%), smaller than the overall mortality reported by older studies of 11-15% [14, 15] . The more recent EMPEROR registry, including however younger patients, reported an in-hospital mortality related to PTE of 1.1% similar to our data [16] . The lower mortality in our study could be partially explained by its retrospective nature and the possible different coding in the electronic system of deaths that occurred in the emergency department without hospital admission. Nonetheless, we found a long hospital stay and more so in the case of older patients reflecting probably the case severity, even though completion of the 5-10 days of the parenteral anticoagulant therapy could have been a deciding factor [6] . However, we found no difference in hospital stay length between patients receiving non-AVK oral anticoagulants versus those receiving parenteral anticoagulant, as opposed to recent studies showing that PTE in patients treated with NOAC had shorter hospital stays [17, 18] .
In-hospital treatment consisted in anticoagulation in almost all patients, with UFH being the preferred anticoagulant (73.7%). Cost and availability could have been an important factor when deciding for UFH, as the ESC guideline recommends UFH especially for high risk PTE, a situation where LMWH were not studied, whereas in intermediate or low-risk PTE LMWH are the first choice. Nonetheless, in the EMPEROR registry including a large U.S. sample, UFH was initiated in 53.6% of patients even though only 3% presented with PTE with shock/hypotension [16] . Only 17.2% received NOAC even though rivaroxaban and apixaban can be safely administered in patients with PTE without shock or hypotension according to the EINSTEIN-PE and AMPLIFY trials and the current ESC guideline [19, 20] . Even apixaban and rivaroxaban were only recently approved and became available in hospitals in Romania. They were however recommended as out-of-hospital anticoagulation in 26.3% of our patients. Nonetheless, the still prohibitive cost of this NOAC could hamper their recommenddation in the following period.
The oral anticoagulant preferred for the outof-hospital anticoagulation was the AVK acenocumarol, an old drug and less costly option for PTE patients from Romania [21] . LMWH at discharge 242 was prescribed to 4 patients with active cancer as recommended by the current guideline.
Apart from anticoagulant treatment, thrombolysis was used in 8.1% of patients of which only a third was used as primary reperfusion therapy, even though 12.6% presented with high risk PTE. The retrospective nature of this study did not allow evaluation for contraindication to reperfusion therapy, even though, according to the current guideline, most contraindications should be considered relative in patients with life-threatening, high-risk PTE [6] .
Study limitations
Our study is a single-center report and its retrospective nature limits the data available for analysis. We could not retrieve data on the timeline and diagnostic steps followed in every patient, therefore, we could only assume the appropriateness of diagnostic tools that were used when following the ESC guideline recommendations. For instance, almost half of patients underwent venous Doppler ultrasound even though its role in PTE diagnostic workup is mainly as an alternative in patients with contraindication to CT angiography [6] .
Moreover, we obtained data from patients admitted starting from January 2014 when NOAC were only becoming available in Romanian hospitals, therefore, the proportion of patients receiving NOAC might be higher now than reported in the current study.
CONCLUSION
In our emergency hospital, PTE is a relatively rare cause of hospitalization; the rate is however comparable with other major hospitals. Dyspnea and pleuritic chest pain was the clinical presentation dyad, while CT angiography was the imaging diagnostic tool in the majority of patients. UFH was the preferred anticoagulant for in-hospital treatment while AVK was the preferred option for long term treatment and recurrence prophylaxis; however, an increasing number of patients are prescribed NOAC. Older patients have higher severity at presentations, longer hospitalization and an increased cancer frequency, younger patients present more with primary hypercoagulable state and recurrent thromboembolism. Mortality rate was low during hospitalization, comparable with that seen in other studied populations. 
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